Immune‐Related Chorea–Ataxia Induced by PD ‐1 Inhibitor (Cemiplimab): A Case Report

Ethical Compliance Statement: This case was reviewed and approved by the Ethics Committee of the Hospital de Amor de Barretos. Written informed consent was obtained from the patient for publication of this case and accompanying video material. We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this work is consistent with those guidelines. Funding Sources and Conflict of Interest: No specific funding was received for this work. The authors declare that there are no conflicts of interest relevant to this work. Financial Disclosures and Conflict of Interest: The authors declare that there are no additional disclosures to report. The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.